Volpara has acquired breast cancer risk assessment company CRA Health, LLC. Volpara Risk™ is now a complete program for identifying and managing high-risk patients. Together we'll apply world-class knowledge about risk and genetics to prevent advanced-stage breast cancer.
Focus on breast cancer risk assessment
Breast cancer risk assessments performed annually
With major Electronic Health Records and genetic testing companies
Digital surveys completed by the patient at home or in the clinic to determine if genetic testing or additional imaging is appropriate.
A complete picture of a patient’s breast cancer risk and breast screening pathways.
Create educational or medical necessity communications for patients, physicians, and payers to advocate for and better coordinate care.
Convenient, easy-to-use system tracks patient progress, updates risk profiles, generates communication, and triggers follow-up.